We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » FDA WANTS DEVICE COMPANIES TO ISSUE RECALLS ELECTRONICALLY

FDA WANTS DEVICE COMPANIES TO ISSUE RECALLS ELECTRONICALLY

May 19, 2006

The FDA is encouraging device companies to use email and other forms of electronic communications such as fax or text messaging to announce voluntary recalls of FDA-regulated products and other important device safety information to the public.

All aspects of recall information can be handled through email or other electronic communication methods, the guidance indicates. Manufacturers can rely on other forms of communication if electronic follow-ups fail, the FDA says.

The guidance notes that electronic communications have a number of advantages over paper-based communications, such as shortening the time safety information becomes available to the public. Email and other electronic communication are cost effective and allow receipt or delivery to be automatically verified, the agency noted.

Moreover, email or other electronic communications are less likely to be discarded than traditional mail. For example, email systems set up in physicians' offices generally allow supplier communications to bypass spam filters.

The guidance offers more leeway in formatting of ecommunications recalls than it does for traditional paper recall letters, but recommends using methods such as marking an email message "Urgent." The communication should also not contain promotional material or links to other promotional materials, the guidance adds.

The complete guidance can be viewed at http://www.fda.gov/oc/guidance/electronic.html (http://www.fda.gov/oc/guidance/electronic.html).

(http://www.fdanews.com/ddl/33_20/)

KEYWORDS FDAnews Device Daily Bulletin

Upcoming Events

  • 08Sep

    Organizing Data and Document Archives: Finding a Needle in a Haystack for FDA Inspections

  • 15Sep

    Califf’s Post-PDUFA, Post-COVID FDA Agenda: Key Developments, Insights and Analysis

  • 20Sep

    Building a World-Class Pharmaceutical Advertising and Promotion Review Program

  • 21Sep

    The FDA’s Focus on Clinical Data Integrity Throughout Product Development and Approval

  • 22Sep

    FDA’s New Quality Management System Regulation: What the Proposed Harmonization with ISO 13485 Means for Devicemakers

  • 11Oct

    1st Annual Quality Management vSummit

Featured Products

  • FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

    FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

  • Selecting and Implementing Electronic Document Management Systems in the EU

    Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

  • AngioDynamics Gets Expanded Clearance for Auryon Atherectomy System

  • Aura Biosciences Receives Fast Track Designation for Bladder Cancer Candidate

  • FDA Issues Update on Becton Dickinson’s Recall

  • FDA Grants Accelerated Approval to Enhertu for HER2-Mutant NSCLC

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing